Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
Clinical trial NCT07509034 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07509034
- Sponsor
- National Cancer Institute (NCI)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-26
- Primary completion
- 2030-01-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.